T. Rowe Price Associates’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,725
| Closed | -$129K | – | 2959 |
|
|
2022
Q1 | $129K | Sell |
10,725
-2,720
| -20% | -$32.7K | ﹤0.01% | 2795 |
|
|
2021
Q4 | $219K | Buy |
13,445
+10,647
| +381% | +$173K | ﹤0.01% | 2720 |
|
|
2021
Q3 | $44K | Hold |
2,798
| – | – | ﹤0.01% | 2901 |
|
|
2021
Q2 | $259K | Sell |
2,798
-3,457
| -55% | -$320K | ﹤0.01% | 2627 |
|
|
2021
Q1 | $325K | Buy |
+6,255
| New | +$325K | ﹤0.01% | 2532 |
|
|
2017
Q4 | – | Sell |
-2,635
| Closed | -$83K | – | 2554 |
|
|
2017
Q3 | $83K | Hold |
2,635
| – | – | ﹤0.01% | 2498 |
|
|
2017
Q2 | $83K | Buy |
2,635
+1,225
| +87% | +$38.6K | ﹤0.01% | 2499 |
|
|
2017
Q1 | $62K | Hold |
1,410
| – | – | ﹤0.01% | 2527 |
|
|
2016
Q4 | $54K | Hold |
1,410
| – | – | ﹤0.01% | 2516 |
|
|
2016
Q3 | $79K | Buy |
+1,410
| New | +$79K | ﹤0.01% | 2468 |
|